aplastic anemia | Page 39 | Aplastic Anemia & MDS International Foundation

aplastic anemia

Reduced intensity conditioning and co-transplantation of unrelated peripheral stem cells combined with umbilical cord mesenchymal stem/stroma cells for young patients with refractory severe aplastic anemia.

Author(s): 
Fu Y, Wang Q, Zhou J, Liu S, Fang B, Wei X, Song Y.
Primary Author: 
Fu Y
Journal Title: 
Int J Hematol
Original Publication Date: 
Nov 2013

Five young patients with a long history of severe

Bone Marrow Diseases: 

Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children.

Author(s): 
Jeong DC, Chung NG, Cho B, Zou Y, Ruan M, Takahashi Y, Muramatsu H, Ohara A, Kosaka Y, Yang W, Kim HK, Zhu X, Kojima S.
Primary Author: 
Jeong DC
Journal Title: 
Haematologica
Original Publication Date: 
Nov 2013

Some prospective studies have shown that rabbit

Bone Marrow Diseases: 

Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia.

Author(s): 
Eckrich MJ, Ahn KW, Champlin RE, Coccia P, Godder K, Horan J, Margolis D, Deeg HJ, Eapen M.
Primary Author: 
Eckrich MJ
Journal Title: 
Am J Hematol
Original Publication Date: 
Oct 2013

We compared outcomes after hematopoietic cell transplantation in patients of African American (n=84) and Caucasian (n=215) descent with severe

Bone Marrow Diseases: 

Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation.

Author(s): 
Marsh JC, Pearce RM, Koh MB, Lim Z, Pagliuca A, Mufti GJ, Perry J, Snowden JA, Vora AJ, Wynn RT, Russell N, Gibson B, Gilleece M, Milligan D, Veys P, Samarasinghe S, McMullin M, Kirkland K, Cook G.
Primary Author: 
Marsh JC
Journal Title: 
Bone Marrow Transplant
Original Publication Date: 
Aug 2013

This retrospective national study compared the use of

Bone Marrow Diseases: